Download FREE Report Sample
Download Free sampleThe global Cardiac Rhythm Management (CRM) Devices market was valued at 96.22 Million USD in 2021 and will grow with a CAGR of 4.58% from 2021 to 2027, based on Research newly published report.
The prime objective of Cardiac Rhythm Management Devices Market is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, Cardiac Rhythm Management Devices Market covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart. A cardiac rhythm management device (CRMD) refers to any permanently implanted cardiac pacemaker or any implantable cardioverter-defibrillator (ICD). The term CRMD also refers to any cardiac resynchronization device. The term CRT refers to a CRMD that provides cardiac resynchronization therapy using biventricular pacing techniques. Increasing instances of heart failure and other cardiac disorders and rising sedentary lifestyle among the population are estimated to boost market growth through 2025. The classification of Cardiac Rhythm Management Device includes Pacemakers, ICD and CRT. And the proportion of Pacemakers in 2017 is about 49.1%. The ICD in 2017 is about 36.6%. Cardiac Rhythm Management Device is widely used in Bradycardia, Tachycardia, heart failure and other. Tachycardia and bradycardia are the most common indications for treatment, heart failure, diabetes and obesity can contribute to ongoing rhythm management concerns. And the market share used tachycardia in 2017 is 42.8%. And the market share used bradycardia in 2018 is 39.9%. North America region is the largest supplier of Cardiac Rhythm Management Device, with a production market share nearly 84.7% in 2017. Europe is the second largest supplier of Cardiac Rhythm Management Device Media, enjoying production market share nearly 12.4% in 2017. North America is the largest consumption place, with a consumption market share nearly 51.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 28.3%, Cardiac Rhythm Management Device market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India. Market competition is intense among top 5. Medtronic, St. Jude Medical (Abbott), Boston Scientific, Biotronik, LivaNova (Sorin) are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
By Market Verdors:
By Types:
By Applications:
Key Indicators Analysed
Key Reasons to Purchase
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy